Bandingkan Harga & Kinerja Indopoly Swakarsa Industry Tbk (IPOL) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indopoly Swakarsa Industry Tbk dan Organon Pharma Indonesia Tbk.: Indopoly Swakarsa Industry Tbk diperdagangkan di Rp115 (kapitalisasi pasar 747,43 M, volume 24 jam 851,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indopoly Swakarsa Industry Tbk jauh lebih besar — sekitar 7,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IPOL | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 747,43 M | 104,4 M |
Volume | 851,1 rb | — |
Lot | 8,51 rb | — |
Perputaran | 98,07 jt | — |
Harga Rata-rata | 115,23 | — |
Nilai Transaksi | 98,07 jt | — |
Harga Ekuilibrium Indikatif | 115 | — |
Volume Ekuilibrium Indikatif | 47 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indopoly Swakarsa Industry Tbk
PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.
Selengkapnya di halaman IPOL →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
